Skip to main content
OpenTrials

Clinical trial condition

Atopic Dermatitis Eczema

Explore clinical trials studying Atopic Dermatitis Eczema. Study availability and eligibility vary by location and protocol.

34 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Atopic Dermatitis Eczema trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT07037901

Conditions
Atopic Dermatitis, Atopic Dermatitis Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Inmagene Site 1 Lancaster, California, United States
  • Inmagene Site 23 Los Angeles, California, United States
  • Inmagene Site 19 Ocala, Florida, United States
  • Inmagene Site 4 Tampa, Florida, United States
View all 23 locations
View Trial Details
Recruiting

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

NCT06855745

Conditions
Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema), +14 more
Locations
  • Canopy Clinical Northern Beaches Brookvale, New South Wales, Australia
  • Momentum Clinical Research Darlinghurst, New South Wales, Australia
  • Premier Specialists Kogarah, New South Wales, Australia
  • St George Dermatology Kogarah, New South Wales, Australia
View Trial Details
Completed

Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

NCT06024499

Conditions
Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp, +11 more
Locations
  • Cahaba Dermatology Skin Health Center Birmingham, Alabama, United States
  • RAOOF MD Dermatology Encino, California, United States
  • L.A. Universal Research Center, Inc. Los Angeles, California, United States
  • Zenith Research Inc. Los Angeles, California, United States
View Trial Details
Completed

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)

NCT04845620

Conditions
Atopic Dermatitis Eczema
Locations
  • Arcutis Clinical Site 56 Birmingham, Alabama, United States
  • Arcutis Clinical Site 14 Birmingham, Alabama, United States
  • Arcutis Clinical Site 69 Montgomery, Alabama, United States
  • Arcutis Clinical Site 68 Gilbert, Arizona, United States
View all 76 locations
View Trial Details
Completed

Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

NCT04804605

Conditions
Atopic Dermatitis Eczema
Locations
  • Arcutis Clinical Site 112 Birmingham, Alabama, United States
  • Arcutis Clinical Site 73 Birmingham, Alabama, United States
  • Arcutis Clinical Site 63 Scottsdale, Arizona, United States
  • Arcutis Clinical Site 106 Bryant, Arkansas, United States
View all 92 locations
View Trial Details

Related conditions